James F. Tessmer, VP, Finance & Accounting at LEXICON PHARMACEUTICALS, INC. (LXRX), sold 1,500 shares at $15.00 ($23K) on 2016-06-06, disclosed to the SEC on 2016-06-08.
Scheduled sale ($22k) by VP, Finance & Accounting under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| LXRX | SELL | 2018-06-12 | $129K | — | Filing → |
| LXRX | SELL | 2016-05-23 | $78K | — | Filing → |